Speaker:
Cindy McCloskey, MD
Director of Clinical Microbiology and Virology, Laboratory Medical Director, OU Health, The University of Oklahoma
Professor of Pathology, The University of Oklahoma College of Medicine
Objectives:
1. Review the history of the emergence of Candida auris and the clinical significance of colonization and disease.
2. Explain strategies for laboratory evaluation for Candida auris, including screening methods, diagnosis of infection, and susceptibility testing.
3. Discuss one laboratory’s evolving strategy for screening for Candida auris.
*SWACM is approved as a Provider of Continuing Education Programs in Clinical Laboratory Sciences by the ASCLS P.A.C.E.® Program. Completion of this program will provide 1.0 contact hour of continuing education. SWACM programs are approved for California-licensed clinical laboratory scientists and personnel. The instructional level of this program is intermediate.
Allison Haas, PhD, D(ABMM), MLS(ASCP)CM
Assistant Medical Director, Barnes Jewish Hospital
Assistant Professor of Pathology and Immunology, Washington University in St. Louis
1. Review the geographical distribution of tick vectors present in the United States.
2. Describe the microorganisms vectored by ticks and their associated clinical syndromes.
3. Discuss available laboratory diagnostics for tick-borne infections.
SWACM is a 501(c)6 non-profit organization. P.O. Box 742857, Dallas, TX 75374-2857